Browse by category

AMGEN presents ‘encouraging’ AMG 133 weight loss results

Amgen revealed new Phase 1 data from AMG 133, a novel bispecific glucose-dependent insulinotropic polypeptide receptor (GIPR) antagonist...

Survey finds 50% of post-bariatric surgery patients feel less stress during the holidays

5 hours ago

Journal Watch 18/12/2024

8 hours ago

True You Weight Loss to initiate two clinical trials assessing gastric fundal mucosal ablation

9 hours ago

Weekly Digest